Back to top
more

Oscar Health (OSCR)

(Delayed Data from NYSE)

$13.82 USD

13.82
19,131,898

-0.02 (-0.14%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $13.90 +0.08 (0.58%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (93 out of 246)

Industry: Insurance - Multi line

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Reasons to Hold American International (AIG) Stock for Now

by Zacks Equity Research

Strong General Insurance business, improving premiums and cost-cutting efforts poise American International (AIG) well for growth.

Zacks Equity Research

Here's Why You Should Retain MetLife (MET) in Your Portfolio

by Zacks Equity Research

MetLife's (MET) growing partnerships, strong U.S. and Latin America segments, and cost-cutting efforts are aiding its margins.

Zacks Equity Research

Oscar Health, Inc. (OSCR) Stock Jumps 56.3%: Will It Continue to Soar?

by Zacks Equity Research

Oscar Health, Inc. (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Why Investors Should Invest in CNO Financial (CNO) Stock Now

by Zacks Equity Research

Strong direct-to-consumer life sales, improving annuity collected premiums and increased Medicare enrolment poise CNO Financial (CNO) well for growth.

Zacks Equity Research

Do Options Traders Know Something About Oscar Health (OSCR) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Oscar Health (OSCR) stock based on the movements in the options market lately.

Zacks Equity Research

Oscar Health, Inc. (OSCR) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -3.96% and 10.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Prudential (PRU) Misses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Prudential (PRU) delivered earnings and revenue surprises of -5.84% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Strength Seen in Lemonade (LMND): Can Its 12.8% Jump Turn into More Strength?

by Zacks Equity Research

Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Old Republic International (ORI) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Old Republic (ORI) delivered earnings and revenue surprises of 63.27% and 1.90%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Oscar Health, Inc. (OSCR) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -19.74% and 5.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

Cigna (CI) delivered earnings and revenue surprises of 5.96% and 1.10%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

American International Group (AIG) Q3 Earnings Surpass Estimates

by Zacks Equity Research

American International Group (AIG) delivered earnings and revenue surprises of 11.86% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

PCB Bancorp (PCB) Q3 Earnings Miss Estimates

by Zacks Equity Research

PCB Bancorp (PCB) delivered earnings and revenue surprises of -32.35% and 2.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Cigna (CI) & Oscar Health Boost Presence in Philadelphia

by Zacks Equity Research

Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.

Zacks Equity Research

Cigna (CI) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Cigna (CI) delivered earnings and revenue surprises of 14.34% and 2.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Trean Insurance (TIG) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

Trean Insurance (TIG) delivered earnings and revenue surprises of 120% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

EverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

EverQuote (EVER) delivered earnings and revenue surprises of 74.47% and 7.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is MetLife (MET) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Are Investors Undervaluing Cigna (CI) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Is MGIC Investment (MTG) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Oscar Health, Inc. (OSCR) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of 10% and 21.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Lemonade (LMND) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Lemonade (LMND) delivered earnings and revenue surprises of 15.38% and 2.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Horace Mann (HMN) Q1 Earnings Lag Estimates

by Zacks Equity Research

Horace Mann (HMN) delivered earnings and revenue surprises of -31.91% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Goosehead Insurance (GSHD) Q1 Earnings Beat Estimates

by Zacks Equity Research

Goosehead (GSHD) delivered earnings and revenue surprises of 300% and 0.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Can Oscar Health, Inc. (OSCR) Climb 162% to Reach the Level Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 162.4% upside potential for Oscar Health, Inc. (OSCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.